The Economic Times
October 22, 2003
Labs gets three patents
SAMI LABS, a Bangalore based Rs 250- crore health biotech
company, has been granted three patents for new active ingredients
in the filed of dermatology, ineffective and geriatric ophthalmology,
which will help in its effort to become a more serious global
player. The patents will pave way for a renewed focus on discovery
and intellectual property, Dr Muhammed Majeed, chairman and
managing director, Sami Labs told ET.
The three new patented active ingredients are Tetrahydrocurcuminoids
(THC), Coleus oil and ZeaLutien, which are set to revolutionise
the dermatology, infective and geriatric ophthalmology markets.
Tetrahydrocurcuminoids are the white curcuminoids converted
from the yellow active ingredient from turmeric. The component
has significant anti-oxidant application and UV protection.
The process of conversion from yellow to white improves bioavailability
and eliminates the staining properties of curcuminoids.
The process of stabilisation of lutein (one of the 600 naturally
occuring fat-soluble antioxidant carotenoid biochemicals that
are found in green leafyvegetables such as spinach) immproves
the longevity of the drug and its prevetion of ARMD Oil extracted
from Coleus Forskohli has strong anti-microbial properties
especially in fighting gram positive infections and dental
microbial activity. It is superior to tree oil popularly used
in India. The ingredients in nutraceuticals and cosmeceuticals
formulations have a combined estimated market size of Rs 20
crore. Sami Labs plans to capture 5% of the market in the
next three years with these discoveries.
The company firmly believes that patents drive discovery and
innovation – reflected in its own strategy of research
based intellectual property and opportunities to scale up
its operations, said Dr Majeed.
Sami Labs at present has a total of 27 international patents
–nine approved, three allowed and 15 more pending, he
“ The Indian business environment is challenging for
us, especially in the absence of strong protection laws against
infringement of intellectual property,” he said and
added that the patents and exclusive marketing rights strengthen
the product life cycle and provide patient populations an
access to better healthcare solutions.
The company is also pursuing the aromas and fragrances market
in India, pegged at Rs 1,200 crore.